AUM Pharmacy
Health Hub
Search Icon

AUM Pharmacy

Hi there!

Hello, Login
All Categories
VisaVisaVisa
slide-0
slide-1

Rapilif-M 25 Tablet ER

Prescription Icon
Prescription Required

Marketer

Ipca Laboratories Ltd

Salt Composition

Mirabegron (25mg) + Silodosin (8mg)

Overview Rapilif-M 25 Tablet ER

Extended-release Rapilif-M 25mg tablets are a combined medication for managing benign prostatic hyperplasia (BPH). They alleviate urinary symptoms such as hesitancy, but don't reduce prostate size. Follow your doctor's prescribed dosage and schedule; consume with or without food, consistently at the same time each day. Swallow whole; avoid crushing or chewing. Discontinuing treatment prematurely may worsen symptoms, so complete the prescribed course for optimal results. Potential side effects include dizziness, diarrhea, retrograde ejaculation, orthostatic hypotension, headache, nasal congestion, and nasopharyngitis. Report persistent or bothersome side effects promptly. Lifestyle modifications can aid symptom control: void when the urge arises, but avoid straining. Limit evening and pre-sleep consumption of caffeine and alcohol. Prior to treatment, disclose all other medications and pre-existing conditions to your physician. If cataract or glaucoma surgery is planned, inform your ophthalmologist about Rapilif-M 25mg use. Individuals with liver or kidney impairment should exercise caution, undergoing regular monitoring as directed by their doctor.

Uses of Rapilif-M 25 Tablet ER

Noncancerous prostate gland enlargement

Major Benefits of Rapilif-M 25 Tablet ER:

Follow your doctor's instructions precisely regarding dosage and treatment length for Rapilif-M 25 Tablet ER. Ingest the tablet whole; do not damage it by chewing, crushing, or breaking. While you may consume it with or without food, consistency is key—take it at the same time each day.

Common Side effects of Rapilif-M 25 Tablet ER:

  • Retrograde ejaculation
  • Dizziness
  • Diarrhea
  • Orthostatic hypotension (sudden lowering of blood pressure on standing)
  • Headache
  • Nasopharyngitis (inflammation of the throat and nasal passages)
  • Nasal congestion (stuffy nose)

How to use Rapilif-M 25 Tablet ER:

Administer this medication precisely as your physician directs, adhering to both the prescribed dosage and treatment length. Ingest the tablet whole; avoid chewing, crushing, or fracturing it. Rapilif-M 25 Tablet ER can be consumed with or without food, although consistent daily timing is recommended.

How Rapilif-M 25 Tablet ER works:

Rapilif-M 25 Extended-Release tablets contain mirabegron and silodosin, working together to ease urinary symptoms. Mirabegron's action on bladder muscles reduces the urge to urinate frequently or uncontrollably. Silodosin complements this by relaxing both bladder and prostate muscles.

SAFETY ADVICE

AlcoholAlcoholCONSULT YOUR DOCTOR

Alcohol consumption alongside Rapilif-M 25 Tablet ER is not definitively established as safe. Seek medical advice before combining them.

PregnancyPregnancyCONSULT YOUR DOCTOR

Data on Rapilif-M 25 Tablet ER use in pregnancy is lacking. Seek medical advice from your physician.

Breast feedingBreast feedingCONSULT YOUR DOCTOR

Data on the compatibility of Rapilif-M 25 Tablet ER with breastfeeding is lacking. Seek medical advice from your physician.

DrivingDrivingCONSULT YOUR DOCTOR

Rapilif-M 25 Tablet ER's effect on driving ability is undetermined. Refrain from driving if experiencing symptoms impairing concentration or reaction time.

KidneyKidneyCONSULT YOUR DOCTOR

Insufficient data exists regarding Rapilif-M 25 Tablet ER's use in individuals with renal impairment. Physician consultation is advised.

LiverLiverCONSULT YOUR DOCTOR

Insufficient data exists regarding the use of Rapilif-M 25 Tablet ER in individuals with hepatic impairment. Physician consultation is advised.

What if you forget to take Rapilif-M 25 Tablet ER :

For Rapilif-M 25 Tablet ER, take any missed dose as soon as you remember unless your next dose is imminent. In that case, omit the missed dose and resume your usual dosing regimen. Avoid taking a double dose.

Facts to Know About Rapilif-M 25 Tablet ER

LabelValue
Developing Habits No.
Type of Therapy Urologic Care

FAQs on Rapilif-M 25 Tablet ER

This medication can lower your blood pressure, most notably with the first dose. Therefore, avoid driving, operating machinery, or engaging in critical tasks initially. Consult your doctor before starting this medication.
Always consult your doctor before starting Rapilif-M 25 Tablet ER. This medication may cause low blood pressure and fainting, a risk heightened by concurrent sildenafil use. Some individuals are particularly susceptible to this potentially dangerous drop in blood pressure and increased risk of fainting.
Continue taking Rapilif-M 25 Tablet ER even if your symptoms improve. This medication doesn't cure benign prostatic hyperplasia, but manages symptoms such as painful and frequent urination, and urgency. Discontinuing treatment could cause symptoms to return.
This medication can lower your blood pressure, especially with the first dose. Therefore, avoid driving, operating machinery, or performing critical tasks initially. Consult your doctor before starting this medication.
Always consult your doctor before starting Rapilif-M 25 Tablet ER. This medication may cause low blood pressure and fainting, a risk heightened by concurrent sildenafil use. Some individuals are particularly susceptible to this dangerous combination, experiencing significantly increased fainting risks.
Continue taking Rapilif-M 25 Tablet ER even if your symptoms improve. This medication doesn't cure benign prostatic hyperplasia, but manages symptoms such as painful and frequent urination, and urgency. Stopping treatment could cause symptoms to return.
Rapilif-M 25 Tablet ER
386
MRP 470
17% off